An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors ; day:14 ; month:5 ; year:2019 ; pages:1-10
Supportive care in cancer ; (14.5.2019), 1-10
- Creator
-
O’Reilly, Aine
Hughes, Peta
Mann, Jasmine
Lai, Zhuangming
Teh, Jhia Jiat
Mclean, Emma
Edmonds, Kim
Lingard, Karla
Chauhan, Dharmisha
Lynch, Joanna
Au, Lewis
Ludlow, Aileen
Pattison, Natalie
Wiseman, Theresa
Turajlic, Samra
Gore, Martin
Larkin, James
Husson, Olga
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-019-04818-w
- URN
-
urn:nbn:de:101:1-2019062500281951874655
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- O’Reilly, Aine
- Hughes, Peta
- Mann, Jasmine
- Lai, Zhuangming
- Teh, Jhia Jiat
- Mclean, Emma
- Edmonds, Kim
- Lingard, Karla
- Chauhan, Dharmisha
- Lynch, Joanna
- Au, Lewis
- Ludlow, Aileen
- Pattison, Natalie
- Wiseman, Theresa
- Turajlic, Samra
- Gore, Martin
- Larkin, James
- Husson, Olga
- SpringerLink (Online service)
Other Objects (12)
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report